ArticleAnnals of transplantation2025
Low-Dose r-ATG vs Basiliximab in Low-Risk Living-Donor Kidney Transplantation: Outcomes in Acute Rejection, Graft Function, and Infections.
Nam Ho et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.